ACRV icon

Acrivon Therapeutics

41 hedge funds and large institutions have $74.6M invested in Acrivon Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

48% less capital invested

Capital invested by funds: $144M → $74.6M (-$69.7M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.7M
2
$14.8M
3
$8.13M
4
$8.12M
5
$4.37M
6
$2.94M
7
$2.78M
8
$2.34M
9
$1.29M
10
$1.11M
11
$931K
12
$656K
13
$646K
14
$460K
15
$394K
16
$337K
17
$252K
18
$227K
19
$164K
20
$157K
21
$157K
22
$122K
23
$121K
24
$65.4K
25
$58.2K